[ed. note: Michael Jorrin, who I like to call Doc Gumshoe, writes mostly non-financial articles about health topics for our readers a couple times a month — he is not a doctor (he’s a longtime medical writer), he chooses his own topics, and his words and opinions are his own. Enjoy!] It was only a […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I've seen few scenarios as embittering as PTN. I just believe mgmt told whopper-size lies to shareholders and we still d...
A $PTN buyout is plausible. Flibanserin (Addyi) was recently approved for FSD and bought by Valeant....
$PTN - - some observations from the presentation. > Slide 7: "Market analysts estimate global market > $2 billi...
Bizbanx -- this link gives a version of the 19-item FSFI questionnaire that was used for both bremelanotide and for flib...
I also read that alcohol is compatible with bremelanotide whereas it's contraindicated in patients on flibanserin (Addyi...
The New York Times reports that Sprout's flibanserin - once dubbed the pink viagra - has proved less than arousing. Mar...
$PTN. Was updating myself today on this stock, which has been discussed here from time to time, and am sharing in case ...
A most excellent point, Kenny. If one puts the best possible spin on PTN it's now easily worth more. The street view, ho...
The couple in Raleigh, NC, who bought and developed flibanserin are quixotic. The till may have little cutter in it when...
John Carroll at Fierce Biotech on the FDA's approval of Flibanserin: http://www.fiercebiotech.com/story/fda-blundered...
And on 06/05/15: Author: Dr. KSS, MD PhD Comment: Sogiam: you were asking about Palatin. This is a pure sucker's ral...
Rae -- agree with you on the merits, but note that it is not possible to invest directly in flibanserin even if one were...
FDA statement on flibanserin approval: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm458734.htm Long $P...
Spelling correction: flibANSERIN. Hate it when that happens....
I have no medical background whatsoever, but I also strongly disagree with the acceptance of flibanserin. imo, at first...
THE REAL PROBLEM WITH FLIBANSERIN: http://www.newyorker.com/cartoons/daily-cartoon/daily-cartoon-friday-june-5th-female...
Interesting and very public battle going on about this drug, and the issues are at least as much politics and perception...
Kenny: and don't doubt flibanserin therapy won't cost at least $500/month and NOT be covered by third party payers. For ...
Kenny---I think much will depend on marketing, but I look at it this way. Flibanserin is premised on a notion that tweak...
Doc - in addition to the warning labels for flibanserin, I had read that the drug provides very modest results, specific...
According to briefing documents, the FDA will likely require physicians intending to prescribe flibanserin for female se...
Sogiam: you were asking about Palatin. This is a pure sucker's rally in its shares, as Sprout's flibanserin story has li...
https://soundcloud.com/bmjpodcasts/the-sex-drug-for-women?utm_source=feedburner-bmj.com+download&utm_medium=feed&utm_cam...
Doc, thanks for your comments and I'm so glad you let the poorly informed author know about PTN. Sprout has done a good ...
Frank: Thanks for asking about flibanserin. My honest view is that Boehringer was wise to divest itself of that product ...
Dr KSS ; as a follow up to PTN have you any thoughts on Sprout pharma 'Flibanserin' for HSDD?...